Definitive Contract 75N91024C00083
Award Date
9/16/24
Potential Completion Date
9/15/27
Potential Value
$2.4M
Federal Agency
National Cancer Institute
Awardee
Doseoptics LLC
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lebanon, NH 03766, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
4
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the National Institutes of Health (NIH), to Radiopharmaceutical Imaging and Dosimetry, LLC, doing business as Radiopharmaceutical Imaging & Dosimetry LLC, a small business. The contract, valued at $299,275, is for a Small Business Innovation Research (SBIR) Phase I project to optimize targeted radionuclide therapy for metastatic liver cancer patients. This contract supports the NCI's broader...
This is a $398,714 firm fixed-price SBIR Phase I contract awarded by the National Cancer Institute (NCI) to Irai Technologies, LLC, a minority-owned small business. The contract is for the development of a flash dosimetry system based on ionizing radiation acoustic imaging, under Solicitation PHS-2023-1 for the NIH and CDC SBIR program. The goal is to contribute toward NCI mission needs and SBIR program objectives by stimulating technological innovation and fostering participation from small,...
This is a $1,980,915.00 firm-fixed-price SBIR Phase II contract awarded by the National Cancer Institute (part of the Department of Health and Human Services) to Pyramid Technical Consultants, Inc., a for-profit manufacturing company, for the development of ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract has a period of performance from September 16, 2024 to September 15, 2026 and is set aside for a small business. The contract was awarded under SBIR Topic 434...
This is a $1,998,978.00 Firm Fixed Price contract awarded by the National Cancer Institute, a civilian federal agency, to Light Research Inc., a for-profit small business. The contract is for Phase 2 of a Small Business Innovation Research (SBIR) program, under Topic 431 "LIGHT RESEARCH". The contract has a Total Small Business set-aside and an ultimate completion date of September 15, 2026. Light Research Inc. is a small business that provides research, development, and...
This is a $396,190 firm fixed price Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (part of the National Institutes of Health) to Tetraimaging LLC, a small disadvantaged business, to develop ultra-fast dose rate (FLASH) radiation detectors and safety systems. The contract was awarded on September 16, 2022 and is set to complete by December 15, 2023. The original solicitation, PHS-2022-1, announced by the NIH and CDC, sought small business...
This is a Firm Fixed Price definitive contract awarded by the National Cancer Institute (NCI), a civilian agency, to Tetraimaging LLC, a self-certified small disadvantaged business. The contract, valued at $1,999,930.00, is for the development of a multilayer strip ion chamber device to measure flash-RT beams under the SBIR (Small Business Innovation Research) Program Phase II. The period of performance is from September 16, 2024, to September 15, 2026, and the contract has a total small...
This is a Firm Fixed Price contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), to Neuralrad LLC, a small business, for $454,559.00. The contract was awarded under the SBIR (Small Business Innovation Research) program to support the development of "Quantitative Imaging Software Tools for Cancer Diagnosis and Treatment Planning" as described in the original solicitation. This Phase I SBIR contract has a period of performance from...
<p>This is a $1,999,984.00 Small Business Innovation Research (SBIR) Phase II contract awarded by the National Cancer Institute (NCI), a civilian agency, to Diacarta, Inc. The contract is for the TOPIC 345 - SBIR PHASE II: RADTOX - MEASURING RADIATION TOXICITY USING CIRCULATING DNA project, which aims to develop a method for measuring radiation toxicity using circulating DNA. The contract has a Firm Fixed Price pricing type and is set to be completed by March 15, 2023.</p>
<p>This is a $1,908,932.02 Firm Fixed Price Definitive Contract awarded by the National Institutes of Health (NIH) National Cancer Institute to Photolitec LLC, a small business limited liability company, for SBIR Phase II research on image-guided photodynamic therapy in combination with chemotherapy for lung cancer treatment. The contract was set aside for Total Small Business and has a completion date of February 18, 2022.</p>
This is a $300,000.00 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a civilian agency, to Icagen, Inc. for a Small Business Innovation Research (SBIR) Phase I project titled "SYSTEMIC TARGETED RADIONUCLIDE THERAPY FOR CANCER TREATMENT". The period of performance is from September 22, 2015 to June 21, 2016, with an ultimate completion date of September 30, 2016. This contract was not set aside for a specific business size or type. The goal of this SBIR...